Features Pricing Newsletter Events Partners

Features Pricing Newsletter Events Partners

Loading people...

Making merit matter more than network. The intelligence layer for Venture fundraising.

Platform

Features Pricing Blog Newsletter Events

Company

Partners About Privacy Terms

Connect

© 2026 Startup Intros. All rights reserved.

Robert Allen: Profile, Experience & Investments | Startup Intros

Home
/People
/Robert Allen

RA

ROBERT ALLEN

Vice President Antiviral and oncolytic immunotherapy development at Sorrento Therapeutics

Updated: Apr 2, 2026 ·

About Experience Investments FAQs

Quick Facts

Role: Vice President Antiviral and oncolytic immunotherapy development
Company: Sorrento Therapeutics
Status: Active
Type: Investor

Subscribe, Save or Share

Get email updates

Experience

Vice President Antiviral and oncolytic immunotherapy developmentCurrent

Sorrento Therapeutics

Present - Present

Frequently Asked Questions

Who is Robert Allen?

Robert Allen is Vice President Antiviral and oncolytic immunotherapy development at Sorrento Therapeutics.